Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

INSYS Therapeutics Inc (NASDAQ:INSY)

15.20
Delayed Data
As of May 24
 +0.87 / +6.07%
Today’s Change
12.21
Today|||52-Week Range
46.17
-46.91%
Year-to-Date
This Marijuana Stock Takes a Step Forward
May 24 / MotleyFool.com - Paid Partner Content
4 Best Stocks in the Thriving Medical Marijuana Industry
May 18 / TheStreet.com - Paid Partner Content
4 Top Stocks in the Growing Medical Marijuana Industry
May 18 / TheStreet.com - Paid Partner Content
What You Need To Know About Investing In Marijuana Stocks
May 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close14.33
Today’s open14.60
Day’s range14.25 - 15.29
Volume1,139,884
Average volume (3 months)814,970
Market cap$1.0B
Dividend yield--
Data as of 4:00pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)+48.08%
Earnings growth (this year)-73.04%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)+48.92%
P/E ratio21.7
Price/Sales6.55
Price/Book4.06

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...+1.04+3.29%
SAGESAGE Therapeutics In...-2.12-6.50%
TBPHTheravance Biopharma...+0.64+3.07%
CLLSCellectis SA-0.01-0.03%
Data as of 4:00pm ET, 05/24/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)$0.08
Annual revenue (last year)$330.8M
Annual profit (last year)$58.5M
Net profit margin17.68%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
John N. Kapoor
Chief Operating Officer &
Executive Vice President
Daniel Brennan
Corporate headquarters
Chandler, Arizona

Forecasts

Partner Offers

Search for Jobs